NRC vs MORN

For growth investors, Morningstar, Inc.

(MORN) is the stronger pick with 7. 5% revenue growth year-over-year, versus -4. 0% for National Research Corporation (NRC). Morningstar, Inc. (MORN) offers the better valuation at 20. 5x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate Morningstar, Inc. (MORN) a "Hold" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Morningstar, Inc.

(MORN) is the cheapest at 20. 5x versus National Research Corporation at 37. 6x. On forward P/E, Morningstar, Inc. is actually cheaper at 15. 3x.

Over the past 5 years, Morningstar, Inc.

(MORN) delivered a total return of -18. 1%, compared to -52. 0% for National Research Corporation (NRC). Over 10 years, the gap is even starker: MORN returned +131. 4% versus NRC's +91. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Morningstar, Inc.

(MORN) is the lower-risk stock at 0. 41β versus National Research Corporation's 0. 80β — meaning NRC is approximately 96% more volatile than MORN relative to the S&P 500. On balance sheet safety, Morningstar, Inc. (MORN) carries a lower debt/equity ratio of 115% versus 6% for National Research Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Morningstar, Inc.

(MORN) is pulling ahead at 7. 5% versus -4. 0% for National Research Corporation (NRC). On earnings-per-share growth, the picture is similar: Morningstar, Inc. grew EPS 3. 4% year-over-year, compared to -50. 0% for National Research Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Morningstar, Inc.

(MORN) is the more profitable company, earning 15. 3% net margin versus 8. 4% for National Research Corporation — meaning it keeps 15. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MORN leads at 21. 5% versus 16. 4% for NRC. At the gross margin level — before operating expenses — MORN leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Morningstar, Inc.

(MORN) trades at 15. 3x forward P/E versus 22. 2x for National Research Corporation — 6. 9x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

National Research Corporation (NRC) offers the highest yield at 2. 5%, versus 1. 0% for Morningstar, Inc. (MORN).

For long-horizon retirement investors, Morningstar, Inc.

(MORN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), 1. 0% yield, +131. 4% 10Y return). Both have compounded well over 10 years (MORN: +131. 4%, NRC: +91. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NRC (Healthcare) and MORN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.